Paclitaxel in Treating Patients With Recurrent or Progressive Advanced Ovarian Cancer

NCT00002928 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: paclitaxel

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]